Hiscox et al. reported the increased expression of c-MET along with a marked increase in the migratory and invasive capacity of Fulvestrant-resistant MC cells, and observed that increased expression of c-MET in endocrine therapy-resistant epithelial MC cells promoted cancer progression [75]. Here, MET is linked to cancer.